IBEX Limited reported $644M of revenue over the trailing twelve months, +15% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $644M (to Q4 2026). Net income: $46M, trailing twelve months to Q4 2026. Free cash flow: $31M, trailing twelve months to Q4 2026. Operating margin: 8.5%, trailing twelve months to Q4 2026.

IBEXIBEX Limited

Technology

$44.38+19% 1Y

$44.38

$26.4052 weeks$44.68

IBEX as reported

IBEX Limited reported $644M of revenue over the trailing twelve months, +15% on the year before. 11 reported series are charted on this page, each one as filed.

$644M

Revenue, trailing twelve months · to Q4 2026 · +15% against the twelve months before

Net income: $46M
Net income · +26% year on year · trailing twelve months to Q4 2026
Free cash flow: $31M
Free cash flow · +14% year on year · trailing twelve months to Q4 2026
Operating margin: 8.5%
Operating margin · trailing twelve months to Q4 2026

Details›

Every series Ryufin has for IBEX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$644M	+15%	Q4 2026
Net income	$46M	+26%	Q4 2026
EPS	$3.13	+31%	Q4 2026
Gross margin	29%	n/a	Q4 2026
Operating margin	8.5%	n/a	Q4 2026
Net margin	7.2%	n/a	Q4 2026
ROE	29%	n/a	Q4 2026
ROA	15%	n/a	Q4 2026
ROIC	31%	n/a	Q4 2026
Free cash flow	$31M	+14%	Q4 2026
P/E	14.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.